𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunosensitization with a Bcl-2 small molecule inhibitor

✍ Scribed by Jonathan Begley; Dan D. Vo; Lilah F. Morris; Kevin W. Bruhn; Robert M. Prins; Stephen Mok; Richard C. Koya; Hermes J. Garban; Begonya Comin-Anduix; Noah Craft; Antoni Ribas

Book ID
105967510
Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
501 KB
Volume
58
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Non-peptidic small molecule inhibitors a
Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy
✍ Asfar S. Azmi; Ramzi M. Mohammad πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 208 KB πŸ‘ 1 views

## Abstract A critical regulator of the apoptotic machinery is the Bcl‐2 family proteins whose over expression confers a protective effect on malignant cells against death signals of apoptosis. Cancer cells that are resistant to various anti‐cancer drugs and treatment regimen are found to over expr

A small-molecule PDGF inhibitor
A small-molecule PDGF inhibitor
✍ Jamison, Judy πŸ“‚ Article πŸ“… 2000 πŸ› Nature Publishing Group 🌐 English βš– 291 KB
Molecular dynamics study of small molecu
Molecular dynamics study of small molecule inhibitors of the Bcl-2 family
✍ StΓ©phane Acoca; Qizhi Cui; Gordon C. Shore; Enrico O. Purisima πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 704 KB

## Abstract We carried out docking and molecular dynamics simulations on ABT‐737 and obatoclax, which are inhibitors of the Bcl‐2 family of proteins. We modeled the binding mode of ABT‐737 with Bcl‐x~L~, Bcl‐2, and Mcl‐1 and examined their dynamical behavior. We found that the binding of the chloro